Atlas Trials

Immunogenicity After COVID-19 Vaccines in Adapted Schedules

Clinical trial NCT06189040 · COMPLETED

Trial details

NCT number
NCT06189040
Sponsor
Universiteit Antwerpen
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Coronavirus Disease 2019COVID-19
Start date
2021-05-26
Primary completion
2021-11-03
Enrollment
580

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.